Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. Mostrar más
Realigning resources to extend runway to mid-2027 Focus on clinical development of RP-1664 (PLK4 inhibitor) and RP-3467 (Polθ ATPase inhibitor), with initial clinical readouts expected beginning...
Heavily-pretreated patients on lunresertib and camonsertib combination achieved 25.9% overall response rate (ORR) in endometrial cancer and 37.5% in platinum-resistant ovarian cancer Nearly half...
Event to be webcast live on Thursday, December 12 at 4:30 p.m. ET Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a Cooperative Research and Development Agreement (CRADA...
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.07 | -5.26315789474 | 1.33 | 1.36 | 1.24 | 223100 | 1.27407779 | CS |
| 4 | -0.04 | -3.07692307692 | 1.3 | 1.48 | 1.2 | 513110 | 1.32509511 | CS |
| 12 | -2.47 | -66.2198391421 | 3.73 | 4.0695 | 1.2 | 446830 | 2.005195 | CS |
| 26 | -2.71 | -68.2619647355 | 3.97 | 4.22 | 1.2 | 252954 | 2.29917892 | CS |
| 52 | -4.92 | -79.6116504854 | 6.18 | 8.49 | 1.2 | 223429 | 3.2237174 | CS |
| 156 | -12.24 | -90.6666666667 | 13.5 | 18.68 | 1.2 | 250255 | 8.86233235 | CS |
| 260 | -30.79 | -96.0686427457 | 32.05 | 46.44 | 1.2 | 216487 | 13.8299667 | CS |
glenn1919
4 semanas hace
al dean
1 mes hace
Arnold25764
1 mes hace
glenn1919
1 mes hace
Monksdream
5 meses hace
Monksdream
9 meses hace
Monksdream
1 año hace
Gator44
3 años hace
ElusTrade
3 años hace
akamaii
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
retireat40
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
ElusTrade
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Laszlo1
3 años hace
Just-Keep-Trying
3 años hace
Just-Keep-Trying
3 años hace
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
